首页> 美国卫生研究院文献>Diagnostics >Guideline for Urine Culture and Biochemical Identification of Bacterial Urinary Pathogens in Low-Resource Settings
【2h】

Guideline for Urine Culture and Biochemical Identification of Bacterial Urinary Pathogens in Low-Resource Settings

机译:低资源环境中尿培养指南和细菌尿声病原菌的生化鉴定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Medical diagnosis in low-resource settings is confronted by the lack of suitable guidelines, protocols and checklists. Online-accessible procedural documents are difficult to find, might be mistranslated or interpreted and usually do not address the needs of developing countries. Urinalysis, one of the most frequently performed diagnostic examinations worldwide, involves a series of tests aiming to detect particular disorders, such as urinary tract infections, kidney disease and diabetes. In this guideline, we present an alternative approach for clinical laboratories with limited resources to identify common bacterial uropathogens. We propose dividing the identification plan into two levels. The implicated pathogen will first be assigned into a bacterial group, basic identification, against which a suitable panel of antimicrobial agents shall be selected for the antimicrobial susceptibility testing (AST). Characterization of the pathogen to the genus or species level, advanced identification, will then be performed to ensure correct reading of the AST results and determine the epidemiology of clinically significant pathogens. Most of the proposed steps in our guideline are tailored to meet the needs of clinical laboratories in low-resource settings. Such guidelines are needed to strengthen the capacity of regional pathology laboratories and to enhance international initiatives on antimicrobial resistance and health equity.
机译:低资源环境中的医学诊断面临缺乏合适的准则,协议和清单。在线可访问的程序文件很难找到,可能会被误解或解释,通常不会满足发展中国家的需求。尿液分析,全球最常见的诊断考试之一,旨在检测特定疾病的一系列测试,例如尿路感染,肾病和糖尿病。在本指南中,我们为临床实验室提供了有限资源的临床实验室,以鉴定常见的细菌尿养激素。我们建议将识别计划分为两个层面。将含有含有的病原体将分配给细菌组,基本鉴定,应选择合适的抗微生物剂面板用于抗微生物易感性测试(AST)。然后将进行病原体的病理学病原体,晚期鉴定,以确保正确读取AST结果并确定临床显着病原体的流行病学。我们指南中的大多数拟议步骤都是根据低资源环境中满足临床实验室的需求的量身定制。需要这些准则来加强区域病理实验室的能力,并加强对抗微生物抵抗和卫生股权的国际倡议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号